Natal'JA A. Barmina

Natal'JA A. Barmina

Auto-generated profile, based on publicly available information

Natal'JA A. Barmina

Leningrad Oblast Regional Anti-Tuberculosis Dispensary, Slantsy, Slantsevsky District, Leningrad Oblast, Russia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2021 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
SDSlantsy Leningrad Oblast Regional Anti-Tuberculosis Dispensary
Slantsy Leningrad Oblast Regional Anti-Tuberculosis Dispensary
NBN.A. Barmina
N.A. Barmina
YKYu.V. Korneev
Yu.V. Korneev
The epidemiological situation of tuberculosis (TB) has been improving steadily in recent years however, in the structure of TB patients, there is a high proportion of patients with multidrugresistant/extensively drug-resistant (XDR) pathogens and people with HIV and TB co-infection. As a result, cases of TB disease in children with many risk factors for unfavorable outcome of therapy are recorded, leading to subsequent relapse. the aim of the work was to analyze possible causes of formation and structure of clinical forms of recurrence of TB in children. A retrospective analysis of outpatient cards and medical records of children of residents of the Leningrad region, who had a TB relapse, was carried out. It has been established that in Leningrad Oblast, there were 3 cases of recidivism of TB among children registered from 2011 to 2020. The main risk factor for the development of primary TB was the lack of immunization against TB due to perinatal contact with an HIV-infected mother. The provoking factors of TB relapse were the occurrence of exogenous superinfection of TB, the presence of HIV infection in the child, the presence of large residual changes after primary TB, close contact with a TB patient with an XDR of the causative agent.

1 September 2025 in Infectious Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
VIVeronika E. Izosimova
Veronika E. Izosimova
NBNatal'JA A. Barmina
Natal'JA A. Barmina
MZMarija P. Zharikova
Marija P. Zharikova
OAOleg Y. Alekseyev
Oleg Y. Alekseyev
OROxana A. Ryzhkova
Oxana A. Ryzhkova
MRMarija I. Romanova
Marija I. Romanova
Background: In this article, we present the results of a multicenter clinical trial of IFN-γ in patients with drug-susceptible and drug-resistant pulmonary Tuberculosis (TB) in routine clinical practice. Objective: This study aimed to confirm the efficacy and safety of IFN-γ administered to patients with TB. Methods: All patients were diagnosed with TB after being tested by bacterioscopic and molecular genetic methods and had no contraindications to standard chemotherapy. Results: Recombinant human IFN-γ proved high efficacy in multi-center clinical trials in routine TB practice. Conclusion: The results show that IFN-γ is efficient and safe in the treatment of pulmonary tuberculosis.

14 August 2026 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
NBN.A. Barmina
N.A. Barmina
NGN.V. Golub
N.V. Golub
LBL.A. Baryshnikova
L.A. Baryshnikova
SSSergey Aleksandrovich Sterlikov
Sergey Aleksandrovich Sterlikov
TAT.V. Andreeva
T.V. Andreeva
The search for new opportunities for early detection of tuberculosis infection (TI) and prevention of tuberculosis (TB) in children from risk groups remains relevant. HIV infection is one of the highest risk factors for TB disease. According to the literature, the ELISPOT method is effective for detecting TI regardless of the presence of immunosuppression. In 2025, in vitro laboratory tests based on the assessment of T-lymphocyte interferon-gamma release (IGRA tests) were introduced into clinical practice in the Russian Federation. This case report demonstrates a case of generalized TB in a school-age child with HIV infection, which was first diagnosed at the age of 13 years when seeking medical attention with complaints. The child was hospitalized with a preliminary diagnosis: Crohn's disease, terminal ileitis, stenosing form, moderate severity, stenosis of the terminal ileum. HIV infection? Anamnestic, general clinical data, and results of additional examination methods (radiological, immunological, microbiological) did not allow confirmation of the etiological nature of TB; obtaining morphological data required an aggressive diagnostic approach. A positive IGRA test (blood test using the ELISPOT method) allowed confirmation of the presence of TI in the child and, in conjunction with clinical and radiological data, established the diagnosis of TB, followed by an effective course of anti-tuberculosis chemotherapy against the background of antiretroviral therapy (ART) and achievement of clinical cure. The positive dynamics of the immune status in the child led to the conversion of negative skin immunological tests for TI to positive, which clearly demonstrates the pathogenetic mechanism of various methods of immunodiagnosis of TI. Changes in approaches to TB screening of the pediatric population involve the use of in vitro tests based on the assessment of T-lymphocyte interferon-gamma release (IGRA tests). Immunodeficiency states of various origins are medical indications for laboratory tests using the ELISPOT method.